semaglutide inflammation in Diabetic Kidney Disease: Integrating Clinical Evidence with Mechanistic Insights Semaglutide/Tirzepatide: Beyond Weight Loss: Shamsah

At two years, tirzepatide yielded greater glycemic control and anthropometric benefits, with markedly higher normoglycemia rates, supporting earlier dual GIP/GLP-1 agonism when metformin response is inadequate

GLP-1 and GIP play an important role in glucose homeostasis, stimulating insulin release and inhibiting glucagon release, resulting in a lowering of blood glucose

Atrial fibrillation may come and go or may happen constantly

SIRT3 lysine deacetylase inhibitors specifically target SIRT3 without affecting its structurally similar counterparts, SIRT1 and SIRT2 185,186

Trials continue to explore methods to reduce risk for patients